05/28/2026
GTC is proud to present and contribute to six scientific posters at ASCO, highlighting new molecular insights across hematologic malignancies, solid tumors, CNS involvement, liquid biopsy, transcriptomics, and machine learning.
This year’s poster topics include:
GTC posters:
Defining APOBEC-like signature in diffuse large B-cell lymphoma and demonstration of distinct transcriptomic profile.
Dominant chromosomal abnormalities in breast cancer metastasis to CNS as compared with systemic metastasis demonstrated by liquid biopsy.
Distinction of FLT3-ITD transcriptomic signature from FLT3-TKD and the frequency of this signature in acute myeloid leukemia without FLT3 mutation.
GTC-affiliated posters:
Comprehensive profiling and clinical utility of CSF-derived cell-free DNA/RNA for evaluation of solid and hematologic malignancies affecting the central nervous system.
TP53 mutation adoption of stromal-adhesion/neuronal-like programs as a driver of stress adaptation and acute myelogenous leukemia cell survival.
A two-axis machine learning framework for cell-of-origin inference in AML: A proof-of-concept study.
Visit GTC at booth #17146 to learn more about the data and how advanced molecular profiling is helping shape the future of precision oncology.
https://genomictestingcooperative.com/asco2026
